AI English summary of an SEC filing — figures as filed
Altria said operating cash flow for 2023 rose to $9.3 billion from $8.3 billion in 2022. The company cited lower income tax payments and lower payments related to the State Settlement Agreements as factors behind the increase.
Key points
AI summaryAltria said operating cash flow for 2023 rose to $9.3 billion from $8.3 billion in 2022. The company cited lower income tax payments and lower payments related to the State Settlement Agreements as factors behind the increase.
The company said it paid approximately $2.75 billion in cash at closing of the NJOY Transaction on June 1, 2023, net of cash acquired, and that it may also pay up to $500 million in additional cash, contingent on FDA authorizations for certain NJOY products. It also received approximately $1.8 billion, including interest, in connection with IQOS in July 2023.
The company said it raised its quarterly dividend rate by 4.3% to $0.98 per share from $0.94 per share in Q3 2023, and that the current annualized dividend rate is $3.92 per share. Dividends paid in 2023 totaled approximately $6.8 billion, up 2.7% from approximately $6.6 billion in 2022.
The company said that as of December 31, 2023, it had cash and cash equivalents of $3.7 billion and $3.0 billion of unused availability under its Credit Agreement. Total long-term debt was $26.2 billion as of year-end 2023 and $26.7 billion as of year-end 2022, all of it fixed-rate debt.
Key figures
Fiscal year ended December 31, 2023
- Revenue
- $24.5B
- Operating income
- $11.5B
- Net income
- $8.1B
- EPS
- $4.57
- Gross profit
- $14.3B
- Operating cash flow
- $9.3B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Altria 2023 Operating Cash Flow $9.3 billion
Altria said operating cash flow for 2023 rose to $9.3 billion from $8.3 billion in 2022. The company cited lower income tax payments and lower payments related to the State Settlement Agreements as factors behind the increase.
Source · Based on the MD&A text of the filing
NJOY Acquisition Payments and IQOS Proceeds
The company said it paid approximately $2.75 billion in cash at closing of the NJOY Transaction on June 1, 2023, net of cash acquired, and that it may also pay up to $500 million in additional cash, contingent on FDA authorizations for certain NJOY products. It also received approximately $1.8 billion, including interest, in connection with IQOS in July 2023.
Source · Based on the MD&A text of the filing
Quarterly Dividend Increase and Dividends Paid
The company said it raised its quarterly dividend rate by 4.3% to $0.98 per share from $0.94 per share in Q3 2023, and that the current annualized dividend rate is $3.92 per share. Dividends paid in 2023 totaled approximately $6.8 billion, up 2.7% from approximately $6.6 billion in 2022.
Source · Based on the MD&A text of the filing
Cash and Long-Term Debt as of Year-End 2023
The company said that as of December 31, 2023, it had cash and cash equivalents of $3.7 billion and $3.0 billion of unused availability under its Credit Agreement. Total long-term debt was $26.2 billion as of year-end 2023 and $26.7 billion as of year-end 2022, all of it fixed-rate debt.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…